{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:58:02Z","timestamp":1794873482918,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T00:00:00Z","timestamp":1644105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T00:00:00Z","timestamp":1644105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The incidence of tongue cancer in young adults is on the rise. This trend is more pronounced in females. Although the aetiology is still unclear, there is mounting evidence that genetic syndromes can play a key role in development of oral cancers in this patient group. We report the first case of oral squamous cell carcinoma (oSCC) in a young adult with an MYH9-related disorder (MYH9-RD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 19-year-old female with a germline<jats:italic>MYH9<\/jats:italic>variant (missense variant in exon 2: c.287C\u2009&gt;\u2009T, (p.Ser96Leu)) was referred to the head and neck surgery department for investigation of a painful, thick right tongue ulcer. She was diagnosed with Epstein syndrome, an MYH9-RD, at 12\u2009years of age. Her main phenotypic features were profound thrombocytopenia and marked renal impairment. The tongue biopsy confirmed SCC. Preoperative positron emission tomography (PET) revealed avidity in the right tongue and ipsilateral level 2A neck lymph node. With substantial preoperative multidisciplinary input, she underwent cancer ablation and microvascular free flap reconstruction. Her pathology showed a 35\u2009mm diameter, 14\u2009mm thick moderately differentiated SCC with perineural and lymphovascular invasion. Two out of 38 right neck nodes were positive for metastasis with extranodal extension. None of the 34 left neck nodes was involved.<\/jats:p><jats:p>She had an uneventful recovery and was discharged home on day 6 postoperative day. On day 15 postoperative day, she had catastrophic bleeding in the neck with a respiratory arrest after a forceful cough. She required an emergency tracheostomy and returned to the theatre for haemostasis. Following a short inpatient stay, she was again discharged home and underwent adjuvant therapy consisting of external beam radiotherapy of 60Gy in 30 fractions. On clinical examination and PET at 6\u2009months after surgery, she had no evidence of disease recurrence.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>MYH9-RD can present with advanced locoregional oral cavity malignancy at an early age. The combination of profound thrombocytopenia and marked renal impairment can impact heavily on routine major head and neck cancer surgery and adjuvant treatment. This rare and challenging condition underlines the importance of early detection of cancer and multidisciplinary team input.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13000-022-01210-x","type":"journal-article","created":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T07:02:31Z","timestamp":1644130951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u201cMYH9 mutation and squamous cell cancer of the tongue in a young adult: a novel case report\u201d"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-8595","authenticated-orcid":false,"given":"Takako Eva","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylie","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-0834","authenticated-orcid":false,"given":"Laveniya","family":"Satgunaseelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-313X","authenticated-orcid":false,"given":"Ruta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4547-6611","authenticated-orcid":false,"given":"Bruce","family":"Ashford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,6]]},"reference":[{"key":"1210_CR1","doi-asserted-by":"publisher","first-page":"104875","DOI":"10.1016\/j.oraloncology.2020.104875","volume":"110","author":"L Satgunaseelan","year":"2020","unstructured":"Satgunaseelan L, Allanson BM, Asher R, Reddy R, Low HTH, Veness M, et al. The incidence of squamous cell carcinoma of the oral tongue is rising in young non-smoking women: An international multi-institutional analysis. Oral Oncol. 2020;110:104875.","journal-title":"Oral Oncol"},{"key":"1210_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.critrevonc.2018.02.013","volume":"125","author":"CP Furquim","year":"2018","unstructured":"Furquim CP, Pivovar A, Amen\u00e1bar JM, Bonfim C, Torres-Pereira CC. Oral cancer in Fanconi anemia: review of 121 cases. Crit Rev Oncol Hematol. 2018;125:35\u201340. https:\/\/doi.org\/10.1016\/j.critrevonc.2018.02.013.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"26","key":"1210_CR3","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","volume":"113","author":"BP Alter","year":"2009","unstructured":"Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood. 2009;113(26):6549\u201357. https:\/\/doi.org\/10.1182\/blood-2008-12-192880.","journal-title":"Blood."},{"issue":"11","key":"1210_CR4","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrm2786","volume":"10","author":"M Vicente-Manzanares","year":"2009","unstructured":"Vicente-Manzanares M, Ma X, Adelstein RS, Horwitz AR. Non-muscle myosin II takes Centre stage in cell adhesion and migration. Nat Rev Mol Cell Biol. 2009;10(11):778\u201390. https:\/\/doi.org\/10.1038\/nrm2786.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1210_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/MOH.0b013e32833c069c","volume":"17","author":"S Kunishima","year":"2010","unstructured":"Kunishima S, Saito H. Advances in the understanding of MYH9 disorders. Curr Opin Hematol. 2010;17(5):405\u201310. https:\/\/doi.org\/10.1097\/MOH.0b013e32833c069c.","journal-title":"Curr Opin Hematol"},{"issue":"5","key":"1210_CR6","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000320335","volume":"37","author":"K Althaus","year":"2010","unstructured":"Althaus K, Greinacher A. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus Med Hemother. 2010;37(5):260\u20137. https:\/\/doi.org\/10.1159\/000320335.","journal-title":"Transfus Med Hemother"},{"issue":"4","key":"1210_CR7","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ckj\/sfz103","volume":"12","author":"R Fernandez-Prado","year":"2019","unstructured":"Fernandez-Prado R, Carriazo-Julio SM, Torra R, Ortiz A, Perez-Gomez MV. MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy. Clin Kidney J. 2019;12(4):488\u201393. https:\/\/doi.org\/10.1093\/ckj\/sfz103.","journal-title":"Clin Kidney J"},{"issue":"3","key":"1210_CR8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/01.md.0000076006.64510.5c","volume":"82","author":"M Seri","year":"2003","unstructured":"Seri M, Pecci A, Di Bari F, Cusano R, Savino M, Panza E, et al. MYH9-related disease: may-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine. 2003;82(3):203\u201315. https:\/\/doi.org\/10.1097\/01.md.0000076006.64510.5c.","journal-title":"Medicine."},{"issue":"04","key":"1210_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1160\/TH09-08-0593","volume":"103","author":"A Savoia","year":"2010","unstructured":"Savoia A, De Rocco D, Panza E, Bozzi V, Scandellari R, Loffredo G, et al. Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. Thromb Haemost. 2010;103(04):826\u201332. https:\/\/doi.org\/10.1160\/TH09-08-0593.","journal-title":"Thromb Haemost"},{"key":"1210_CR10","unstructured":"Savoia A, Pecci A. MYH9-related disorders. 2015."},{"issue":"9","key":"1210_CR11","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1158\/0008-5472.CAN-05-4236","volume":"66","author":"V Betapudi","year":"2006","unstructured":"Betapudi V, Licate LS, Egelhoff TT. Distinct roles of nonmuscle myosin II isoforms in the regulation of MDA-MB-231 breast cancer cell spreading and migration. Cancer Res. 2006;66(9):4725\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4236.","journal-title":"Cancer Res"},{"key":"1210_CR12","doi-asserted-by":"publisher","unstructured":"Katono K, Sato Y, Jiang S-X, Kobayashi M, Nagashio R, Ryuge S, et al. Prognostic significance of MYH9 expression in resected non-small cell lung cancer. PLoS One. 2015;10(3):e0121460. https:\/\/doi.org\/10.1371\/journal.pone.0121460.","DOI":"10.1371\/journal.pone.0121460"},{"key":"1210_CR13","doi-asserted-by":"publisher","unstructured":"Schramek D, Sendoel A, Segal JP, Beronja S, Heller E, Oristian D, et al. Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas. Science. 2014;343(6168):309\u201313. https:\/\/doi.org\/10.1126\/science.1248627.","DOI":"10.1126\/science.1248627"},{"issue":"5","key":"1210_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1442-2050.2011.01261.x","volume":"25","author":"Z Xia","year":"2012","unstructured":"Xia Z, Yuan Y, Yin N, Yin B, Tan Z, Hu Y. Nonmuscle myosin IIA is associated with poor prognosis of esophageal squamous cancer. Dis Esophagus. 2012;25(5):427\u201336. https:\/\/doi.org\/10.1111\/j.1442-2050.2011.01261.x.","journal-title":"Dis Esophagus"},{"issue":"14","key":"1210_CR15","doi-asserted-by":"publisher","first-page":"22991","DOI":"10.18632\/oncotarget.14967","volume":"8","author":"SD Coaxum","year":"2017","unstructured":"Coaxum SD, Tiedeken J, Garrett-Mayer E, Myers J, Rosenzweig SA, Neskey DM. The tumor suppressor capability of p53 is dependent on non-muscle myosin IIA function in head and neck cancer. Oncotarget. 2017;8(14):22991\u20133007. https:\/\/doi.org\/10.18632\/oncotarget.14967.","journal-title":"Oncotarget."},{"issue":"7536","key":"1210_CR16","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"CGA Network","year":"2015","unstructured":"Network CGA. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576\u201382. https:\/\/doi.org\/10.1038\/nature14129.","journal-title":"Nature."},{"key":"1210_CR17","doi-asserted-by":"publisher","unstructured":"Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333(6046):1154\u20137. https:\/\/doi.org\/10.1126\/science.1206923.","DOI":"10.1126\/science.1206923"},{"key":"1210_CR18","doi-asserted-by":"publisher","unstructured":"Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011;333(6046):1157\u201360. https:\/\/doi.org\/10.1126\/science.1208130.","DOI":"10.1126\/science.1208130"},{"issue":"47","key":"1210_CR19","doi-asserted-by":"publisher","first-page":"35873","DOI":"10.1074\/jbc.M605343200","volume":"281","author":"JC Sandquist","year":"2006","unstructured":"Sandquist JC, Swenson KI, DeMali KA, Burridge K, Means AR. Rho kinase differentially regulates phosphorylation of nonmuscle myosin II isoforms a and B during cell rounding and migration. J Biol Chem. 2006;281(47):35873\u201383. https:\/\/doi.org\/10.1074\/jbc.M605343200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1210_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ncb1540","volume":"9","author":"S Even-Ram","year":"2007","unstructured":"Even-Ram S, Doyle AD, Conti MA, Matsumoto K, Adelstein RS, Yamada KM. Myosin IIA regulates cell motility and actomyosin\u2013microtubule crosstalk. Nat Cell Biol. 2007;9(3):299\u2013309. https:\/\/doi.org\/10.1038\/ncb1540.","journal-title":"Nat Cell Biol"},{"issue":"6200","key":"1210_CR21","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1256965","volume":"345","author":"RJ Petrie","year":"2014","unstructured":"Petrie RJ, Koo H, Yamada KM. Generation of compartmentalized pressure by a nuclear piston governs cell motility in a 3D matrix. Science. 2014;345(6200):1062\u20135. https:\/\/doi.org\/10.1126\/science.1256965.","journal-title":"Science."},{"key":"1210_CR22","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.gene.2018.04.048","volume":"664","author":"A Pecci","year":"2018","unstructured":"Pecci A, Ma X, Savoia A, Adelstein RS. MYH9: structure, functions and role of non-muscle myosin IIA in human disease. Gene. 2018;664:152\u201367. https:\/\/doi.org\/10.1016\/j.gene.2018.04.048.","journal-title":"Gene."},{"issue":"1","key":"1210_CR23","first-page":"1","volume":"5","author":"MA Conti","year":"2015","unstructured":"Conti MA, Saleh AD, Brinster LR, Cheng H, Chen Z, Cornelius S, et al. Conditional deletion of nonmuscle myosin II-A in mouse tongue epithelium results in squamous cell carcinoma. Sci Rep. 2015;5(1):1\u201311.","journal-title":"Sci Rep"},{"key":"1210_CR24","volume-title":"GeneReviews\u00ae[Internet]","author":"A Savoia","year":"2021","unstructured":"Savoia A, Pecci A. MYH9-related disease. In: GeneReviews\u00ae[Internet]. Seattle: University of Washington; 2021."},{"key":"1210_CR25","doi-asserted-by":"crossref","unstructured":"Yoshioka Y, Sakaue T, Matsui K, Tsushima K, Obayashi F, Hamada A, et al. Clinical investigation of oral cancer in adolescent and young adult generation. In: Oral Science International. 2021.","DOI":"10.1002\/osi2.1093"},{"issue":"5","key":"1210_CR26","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3858\/emm.2008.40.5.486","volume":"40","author":"D-H Shin","year":"2008","unstructured":"Shin D-H, Kim O-H, Jun H-S, Kang M-K. Inhibitory effect of capsaicin on B16-F10 melanoma cell migration via the phosphatidylinositol 3-kinase\/Akt\/Rac1 signal pathway. Exp Mol Med. 2008;40(5):486\u201394. https:\/\/doi.org\/10.3858\/emm.2008.40.5.486.","journal-title":"Exp Mol Med"},{"key":"1210_CR27","doi-asserted-by":"publisher","unstructured":"Zhao K, Wei L, Hui H, Dai Q, You Q-D, Guo Q-L, et al. Wogonin suppresses melanoma cell B16-F10 invasion and migration by inhibiting Ras-medicated pathways. PLoS One. 2014;9(9):e106458. https:\/\/doi.org\/10.1371\/journal.pone.0106458.","DOI":"10.1371\/journal.pone.0106458"},{"issue":"2","key":"1210_CR28","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/or.2013.2883","volume":"31","author":"P Kosza\u0142ka","year":"2014","unstructured":"Kosza\u0142ka P, Pryszlak A, Go\u0142u\u0144ska M, Kolasa J, Stasi\u0142oj\u0107 G, Sk\u0142adanowski AC, et al. Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo. Oncol Rep. 2014;31(2):819\u201327. https:\/\/doi.org\/10.3892\/or.2013.2883.","journal-title":"Oncol Rep"},{"issue":"1","key":"1210_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"N Abd Razak","year":"2019","unstructured":"Abd Razak N, Abu N, Ho WY, Zamberi NR, Tan SW, Alitheen NB, et al. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Sci Rep. 2019;9(1):1\u201312.","journal-title":"Sci Rep"},{"issue":"1","key":"1210_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1442-200X.2012.03619.x","volume":"55","author":"S Murayama","year":"2013","unstructured":"Murayama S, Akiyama M, Namba H, Wada Y, Ida H, Kunishima S. Familial cases with MYH9 disorders caused by MYH9 S96L mutation. Pediatr Int. 2013;55(1):102\u20134. https:\/\/doi.org\/10.1111\/j.1442-200X.2012.03619.x.","journal-title":"Pediatr Int"},{"issue":"2","key":"1210_CR31","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/humu.22476","volume":"35","author":"A Pecci","year":"2014","unstructured":"Pecci A, Klersy C, Gresele P, Lee KJ, De Rocco D, Bozzi V, et al. MYH 9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype\u2013phenotype correlations. Hum Mutat. 2014;35(2):236\u201347. https:\/\/doi.org\/10.1002\/humu.22476.","journal-title":"Hum Mutat"},{"issue":"12","key":"1210_CR32","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1160\/TH05-06-0424","volume":"94","author":"M Eugster","year":"2005","unstructured":"Eugster M, Reinhart WH. The influence of the haematocrit on primary haemostasis in vitro. Thromb Haemost. 2005;94(12):1213\u20138. https:\/\/doi.org\/10.1160\/TH05-06-0424.","journal-title":"Thromb Haemost"},{"issue":"06","key":"1210_CR33","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1160\/TH12-01-0005","volume":"107","author":"A Pecci","year":"2012","unstructured":"Pecci A, Barozzi S, d\u2019Amico S, Balduini CL. Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. Thromb Haemost. 2012;107(06):1188\u20139. https:\/\/doi.org\/10.1160\/TH12-01-0005.","journal-title":"Thromb Haemost"},{"issue":"3","key":"1210_CR34","doi-asserted-by":"publisher","first-page":"e793","DOI":"10.1542\/peds.2012-3807","volume":"132","author":"R Favier","year":"2013","unstructured":"Favier R, Feriel J, Favier M, Denoyelle F, Martignetti JA. First successful use of eltrombopag before surgery in a child with MYH9-related thrombocytopenia. Pediatrics. 2013;132(3):e793\u20135. https:\/\/doi.org\/10.1542\/peds.2012-3807.","journal-title":"Pediatrics."},{"issue":"1","key":"1210_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1213\/XAA.0000000000000621","volume":"10","author":"R Favier","year":"2018","unstructured":"Favier R, De Carne C, Elefant E, Lapusneanu R, Gkalea V, Rigouzzo A. Eltrombopag to treat thrombocytopenia during last month of pregnancy in a woman with MYH9-related disease: a case report. A A Pract. 2018;10(1):10\u20132. https:\/\/doi.org\/10.1213\/XAA.0000000000000621.","journal-title":"A A Pract"},{"issue":"9","key":"1210_CR36","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s00277-015-2416-x","volume":"94","author":"J Yamanouchi","year":"2015","unstructured":"Yamanouchi J, Hato T, Kunishima S, Niiya T, Nakamura H, Yasukawa M. A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia. Ann Hematol. 2015;94(9):1599\u2013600. https:\/\/doi.org\/10.1007\/s00277-015-2416-x.","journal-title":"Ann Hematol"},{"issue":"3","key":"1210_CR37","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5527\/wjn.v6.i3.86","volume":"6","author":"S Ozkok","year":"2017","unstructured":"Ozkok S, Ozkok A. Contrast-induced acute kidney injury: a review of practical points. World J Nephrol. 2017;6(3):86\u201399. https:\/\/doi.org\/10.5527\/wjn.v6.i3.86.","journal-title":"World J Nephrol"},{"key":"1210_CR38","doi-asserted-by":"publisher","unstructured":"Heller PG, Pecci A, Glembotsky AC, Savoia A, Negro FD, Balduini CL, et al. Unexplained recurrent venous thrombosis in a patient with MYH 9-related disease. Platelets. 2006;17(4):274\u20135. https:\/\/doi.org\/10.1080\/17476930500467235.","DOI":"10.1080\/17476930500467235"},{"issue":"3","key":"1210_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1600-0609.2007.00913.x","volume":"79","author":"K Selleng","year":"2007","unstructured":"Selleng K, Lubenow LE, Greinacher A, Warkentin TE. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome). Eur J Haematol. 2007;79(3):263\u20138. https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00913.x.","journal-title":"Eur J Haematol"},{"key":"1210_CR40","doi-asserted-by":"publisher","unstructured":"Gravvanis AI, Tsoutsos DA, Lykoudis EG, Iconomou TG, Tzivaridou DV, Papalois AE, et al. Microvascular repair following crush-avulsion type injury with vein grafts: effect of direct inhibitors of thrombin on patency rate. Microsurgery. 2003;23(4):402\u20137. https:\/\/doi.org\/10.1002\/micr.10146.","DOI":"10.1002\/micr.10146"},{"key":"1210_CR41","doi-asserted-by":"publisher","unstructured":"Landsverk SA, Kvandal P, Kjelstrup T, Benko U, Bernjak A, Stefanovska A, et al. Human skin microcirculation after brachial plexus block evaluated by wavelet transform of the laser Doppler flowmetry signal. Anesthesiology. 2006;105(3):478\u201384. https:\/\/doi.org\/10.1097\/00000542-200609000-00010.","DOI":"10.1097\/00000542-200609000-00010"},{"issue":"8","key":"1210_CR42","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.biopha.2006.07.012","volume":"60","author":"M Rossi","year":"2006","unstructured":"Rossi M, Carpi A, Galetta F, Franzoni F, Santoro G. The investigation of skin blood flowmotion: a new approach to study the microcirculatory impairment in vascular diseases? Biomed Pharmacother. 2006;60(8):437\u201342. https:\/\/doi.org\/10.1016\/j.biopha.2006.07.012.","journal-title":"Biomed Pharmacother"},{"key":"1210_CR43","doi-asserted-by":"publisher","unstructured":"L\u00e1szl\u00f3 I, Janovszky \u00c1, Lovas A, Varg\u00e1n V, \u00d6veges N, T\u00e1nczos T, et al. Effects of goal-directed crystalloid vs. colloid fluid therapy on microcirculation during free flap surgery: a randomised clinical trial. Eur J Anaesthesiol. 2019;36(8):592\u2013604. https:\/\/doi.org\/10.1097\/EJA.0000000000001024.","DOI":"10.1097\/EJA.0000000000001024"},{"key":"1210_CR44","first-page":"4448","volume":"23","author":"J Kaciulyte","year":"2019","unstructured":"Kaciulyte J, Losco L, Maruccia M, Delia G, TORTO F, Di Taranto G, et al. Postsurgical antithrombotic therapy in microsurgery: our protocol and literature. Eur Rev Med Pharmacol Sci. 2019;23:4448\u201357.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"1210_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/00015458.2006.11679863","volume":"106","author":"J-P Lecoq","year":"2006","unstructured":"Lecoq J-P, Senard M, Hartstein G, Lamy M, Heymans O. Thromboprophylaxis in microsurgery. Acta Chir Belg. 2006;106(2):158\u201364. https:\/\/doi.org\/10.1080\/00015458.2006.11679863.","journal-title":"Acta Chir Belg"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-022-01210-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-022-01210-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T02:38:46Z","timestamp":1674700726000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-022-01210-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,6]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1210"],"URL":"https:\/\/doi.org\/10.1186\/s13000-022-01210-x","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,6]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained and is available for review by the editor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no completing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}